Key result
Ideal modifiable risk factor profiles linked to up to ~31% lower lifetime cancer risk.
Why the study?
Despite patient demand for cancer screening and prevention, physicians lack strong data or guidelines on how to approach risk assessment in clinical practice.
Population
446,795 patients in the UK Biobank
Comparison
Baseline risk factor profiles vs achieving healthy risk factor profiles
Design
Risk-modeling study using population cohort data
Authors
Loading...
May warrant individualized risk factor optimization in prevention counseling; extends evidence for precision approaches over age-based criteria.
Lifetime cancer risk varies widely across the population but decreases substantially with healthy behaviors, highlighting the potential for individualized precision prevention approaches over age-based criteria alone.
Butala et al. (2026) studied this question. Achieving ideal modifiable risk factor profiles reduced median lifetime cancer risk from 29.5% to 20.5% in men and from 21.0% to 16.5% in women.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: